Compare
5 stocks, side by sideRelative performance · rebased to 100
GLUETYRARAPPMESOTSHA
| GLUEMonte Rosa Therapeutics, Inc. | TYRATyra Biosciences, Inc. | RAPPRapport Therapeutics, Inc. | MESOMesoblast Limited | TSHATaysha Gene Therapies, Inc. | |
|---|---|---|---|---|---|
| Smart Score | 5/10 | 6/10 | 9/10 | - | 5/10 |
| Price | $21.66 | $30.94 | $38.91 | $14.50 | $6.21 |
| 1 month | +13% | -7.9% | -2.0% | -2.7% | +11% |
| 1 year | +357% | +218% | +214% | +39% | +162% |
| 5 year | - | - | - | -13% | -75% |
| P/E (TTM) | -14.1 | -14.0 | -17.3 | - | -13.7 |
| P/E vs sector | - | - | - | - | - |
| Market cap | $1.8B | $1.8B | $1.9B | $1.9B | $1.8B |
| Sector | Healthcare | Healthcare | Healthcare | Healthcare | Healthcare |
Risk / Return · past yearAnnualized return vs volatility, up-and-left is more reward for less risk.
Correlation · do they move together?Pairwise daily-return correlation over the past year, high = one bet, low = diversifying.